Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Sep 30;7(3):50-55.
doi: 10.4322/acr.2017.029. eCollection 2017 Jul-Sep.

Native-valve endocarditis caused by Achromobacter xylosoxidans: a case report and review of literature

Affiliations
Case Reports

Native-valve endocarditis caused by Achromobacter xylosoxidans: a case report and review of literature

Caio Godoy Rodrigues et al. Autops Case Rep. .

Abstract

Achromobacter xylosoxidans is a Gram-negative aerobic bacterium first described by Yabuuchi and Ohyama in 1971. A. xylosoxidans is frequently found in aquatic environments. Abdominal, urinary tract, ocular, pneumonia, meningitis, and osteomyelitis are the most common infections. Infective endocarditis is rare. As far as we know, until now, only 19 cases have been described, including this current report. We report the case of community-acquired native valve endocarditis caused by A. xylosoxidans in an elderly patient without a concomitant diagnosis of a malignancy or any known immunodeficiency. The patient presented with a 2-month history of fever, weight loss, and progressive dyspnea. On physical examination, mitral and aortic murmurs were present, along with Janeway's lesions, and a positive blood culture for A. xylosoxidans. The transesophageal echocardiogram showed vegetation in the aortic valve, which was consistent with the diagnosis of infective endocarditis.

Keywords: Achromobacter; Infective Endocarditis; Native-Valve Endocarditis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None

Figures

Figure 1
Figure 1. Janeway’s lesions in the patient’s hand.

Similar articles

Cited by

References

    1. Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol. 1971;15(5):477-81. http://dx.doi.org/10.1111/j.1348-0421.1971.tb00607.x. - DOI - PubMed
    1. Derber C, Elam K, Forbes BA, Bearman G. Achromobacter species endocarditis: a case report and literature review. Can J Infect Dis Med Microbiol. 2011;22(3):e17-20. http://dx.doi.org/10.1155/2011/527412. - DOI - PMC - PubMed
    1. Gómez-Cerezo J, Suárez I, Ríos JJ, et al. . Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis. 2003;22(6):360-3. http://dx.doi.org/10.1007/s10096-003-0925-3. - DOI - PubMed
    1. Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidansbacteremia: report of four cases and review of the literature. Clin Infect Dis. 1996;23(3):569-76. http://dx.doi.org/10.1093/clinids/23.3.569. - DOI - PubMed
    1. Kumar S, Khaira J, Penigalapati D. Native valve endocarditis in a dialysis patient by Achromobacter xylosoxidans: Rare pathogen. Open Forum Infect Dis. 2016;3(Suppl 1):1106 http://dx.doi.org/10.1093/ofid/ofw172.809. - DOI - PMC - PubMed

Publication types